<p>Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs

Published:2020-01 Issue: Volume:Volume 13 Page:77-87
ISSN:1178-6965
Container-title:Journal of Asthma and Allergy
language:en
Short-container-title:JAA

Author:

Llanos Jean-Pierre,Ortega Hector,Bogart Michael,Packnett Elizabeth R,Manjelievskaia Janna,Bell Christopher F,Hahn Beth^ORCID

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE AUTHORS RESPOND;Journal of Managed Care & Specialty Pharmacy;2024-04

2. COMMENT ON MODEL INPUTS AND ASSUMPTIONS FOR THE COST-MINIMIZATION MODEL USED TO COMPARE COST OF BIOLOGICS IN SEVERE ASTHMA;Journal of Managed Care & Specialty Pharmacy;2024-04

3. Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

4. Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review;Cureus;2023-12-01

5. Real-world effectiveness of dupilumab in patients with asthma;Annals of Allergy, Asthma & Immunology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP